All news articles for June 2021

Pic:getty/CG6images

FDA approves Biogen’s Alzheimer's drug, Aduhelm

By Rachel Arthur

The US Food and Drug Administration (FDA) has approved Biogen’s Aduhelm (aducanumab) for the treatment of Alzheimer’s: making it the first new treatment approved for the disease since 2003.

(adrian825/iStock via Getty Images Plus)

People on the Move: June 2021

By Jenni Spinner

This month’s roundup of hires, acquisitions, anniversaries, and other announcements includes news from Premier Research, Cytel, ACG, and other companies.

Follow us

Products

View more

Webinars